WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) announced it has approved the nomination of Quest Diagnostics CEO Stephen H. Rusckowski, as Chairman of the Board for the national association representing clinical laboratories. Mr. Rusckowski was nominated by the ACLA Board of Directors and approved by the membership during ACLA’s annual conference.
“Clinical laboratory testing provides insights that help improve healthcare decision making, yet this industry faces unprecedented challenges getting paid appropriately by the government for the service it provides,” said Alan Mertz, President of ACLA. “Clinical laboratories face myriad legislative and regulatory challenges while they continue to provide critical information in the diagnosis and treatment of millions of patients. Steve Rusckowski brings experience and vision to the position of Chairman of our trade association and will be an exemplary leader in helping to address ongoing key policy issues for the lab industry.”
Mr. Rusckowski has served as President and CEO of Quest Diagnostics Incorporated since May 2012. Prior to his tenure at Quest Diagnostics, Mr. Rusckowski was the Chief Executive Officer of Philips Healthcare, the largest unit of Royal Philips Electronics.
“I am very pleased to serve as Chairman of an excellent Board of Directors comprised of leaders committed to the clinical laboratory industry,” said Mr. Rusckowski. “Clinical labs are at the forefront of most healthcare decisions as we take cutting edge technologies and produce information that literally saves lives. The value and importance of these life-saving, life-enhancing technologies is being minimized by lack of fair and accurate reimbursement in public programs such as Medicare, Medicaid and Tricare. This is a pivotal time for our industry and I welcome the opportunity to work with my colleagues to achieve logical and appropriate policy.”
Mr. Rusckowski continued: “Clearly diagnostic information services – our industry – provides enormous value to the healthcare system. Specifically, free preventive screening services are a cornerstone of the Affordable Care Act. Therefore, as a society we should be investing more in diagnostic information services – not cutting them.”